• Assistant Professor, Division of Blood and Marrow Transplantation
  • Department of Pediatrics, Medical School

Weston Miller, MD, is an assistant professor of Pediatrics in the Division of Blood and Marrow Transplantation. Miller is focused on looking at the next generation of transplant protocols and finding the best balance of therapies that deliver a successful patient outcome, while limiting toxicity. As part of the care team for patients with inherited metabolic disorders, Miller is investigating strategies to increase the rate of donor engraftment for this group of patients. His hope is that this work will lead to treatment protocols for other transplant patient groups.     

Expert in:
  • Professor, Division of Pediatric Endocrinology
  • Division Chief of Pediatric Endocrinology and Diabetes
  • Department of Pediatrics, Medical School

Antoinette Moran, MD, strives every day to make a difference in the lives of her patients with type 1 diabetes and cystic fibrosis related diabetes (CFRD). Moran is division chief of Pediatric Endocrinology and Diabetes at the University of Minnesota and she has been taking care of patients with diabetes since 1987. Her research in CFRD resulted in her being named the first annual recipient of the Cystic Fibrosis Foundation’s Richard C. Talamo Distinguished Clinical Achievement Award, for “research contributions that have had significant influence on the course of the disease.” She recently co-chaired a national consensus conference on guidelines for the management of CFRD, sponsored by the Cystic Fibrosis Foundation, the American Diabetes Association and the Pediatric Endocrine Society. Moran is currently studying the prevention and cure of type 1 diabetes as part of TrialNet and the Immune Tolerance Network.  For the last 6 years she has been helping to develop pediatric diabetes programs in East Africa.

Expert in:
  • Professor, Department of Pediatrics, Medical School
  • Co-Director, Center for Infectious Diseases and Microbiology Translational Research (CIDMTR)

Mark Schleiss, MD, is a professor in the Department of Pediatrics and division director of Pediatric Infectious Diseases. Dr. Schleiss has received awards for his work and is a member of various research societies. Dr. Schleiss was also named one of the Best Doctors in America in 2011-2012, 2013. Dr. Schleiss focuses on the study of CMV (Cytomegalovirus) vaccines, immunopathogenesis, and placental infection. Currently, Schleiss’ lab is using animals to evaluate the extent of protection the maternal-placental-fetal unit provides against CMV. 

  • Professor, School of Nursing
  • Member, Center for Child and Family Health Promotion Research
  • Member, Center for Adolescent Nursing

Renee Sieving, PhD, RN, PNP, is available to discuss opportunities for improvements in the health and well-being of vulnerable groups of teens and pre-teens. Her areas of expertise include the prevention of teen pregnancy and sexually transmitted diseases, dropping out of school and youth violence.   

  • Dean, Medical School
  • Vice President for Academic Clinical Affairs, Academic Health Center
  • McKnight University Distinguished Professor, Department of Pediatrics
  • Edmund Wallace Tulloch and Anna Marie Tulloch Chair, Stem Cell Biology, Genetics and Genomics
  • Director, University of Minnesota Stem Cell Institute

Jakub Tolar, MD, PhD, dean of the Medical School and vice president for Academic Clinical Affairs at the Academic Health Center, is at the forefront of blood and marrow transplantation for bone marrow failure and metabolic disorders. His research focuses on the use of bone marrow derived stem cells for correcting genetic diseases and improving the outcomes for blood and marrow transplant patients. Tolar’s research is also investigating novel gene and cellular therapy for organs, such as heart, brain and bone, that are resistant to correction with bone marrow transplantation. Most recently, he was recognized for his work in using a blood and marrow transplant of stem cells to treat severe forms of a rare skin disease called epidermolysis bullosa, or EB. Tolar is a member of the Masonic Cancer Center’s Transplant Biology and Therapy Research Program.  

  • Professor, Department of Pediatrics
  • Director, Blood and Marrow Transplantation
  • Department of Pediatrics, Scientific Director of Clinical Research, Stem Cell Institute
  • Co-Director, Center for Translational Medicine
  • Children’s Cancer Research Fund/Hageboeck Family Endowed Chair in Pediatric Oncology
  • McKnight Presidential Chair in Childhood Cancer Research

John E. Wagner, Jr., MD, is at the forefront of blood and marrow transplantation. He specializes in research and treatment of children with cancer. Dr. Wagner has led the University of Minnesota’s Cord Blood Transplantation Program in the treatment of adults and children and is responsible for its international prominence, having first pioneered its use in 1990 in leukemia. Wagner also specializes in Fanconi anemia and the use of stem cells in severe forms of a rare skin disease called epidermolysis bullosa, or EB. Recently, Wagner has begun research on the development of novel stem cell and immune-based therapies derived from cord blood, including the isolation and expansion of hematopoietic stem cells to reduce the time of blood and marrow recovery, regulatory T cells to control graft-versus-host disease (GVHD) and thymic progenitor cells to enhance immune recovery and reduce the risk of relapse and infections after transplantation. Wagner is the co-leader of the Masonic Cancer Center’s Transplant Biology and Therapy Research Program.